United States Antibacterial Drug Resistance Market Report 2017

Report Description

This report studies sales (consumption) of Antibacterial Drug Resistance in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

  • AAIPharma Services
  • ANTABIO
  • Abgentis
  • Abbott Laboratories
  • Absynth Biologics
  • Achaogen
  • Acino Holdings
  • Aventis Pharma
  • Austell Laboratories
  • Assembly Biosciences
  • Arpida
  • Demuris
  • Evolva Holding
  • ContraFect
  • Cerexa
  • GSK
  • InterMune
  • Isis Pharmaceuticals
  • Lyndra
  • Microbecide
  • Morphochem
  • Nabriva Therapeutics
  • NanoSafe Coatings
  • Novexel
  • Osel
  • PENDOPHARM
  • Pfizer
  • VenatoRx Pharmaceuticals

Market Segment by States, covering

  • California
  • Texas
  • New York
  • Florida
  • Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

  • Telavancin (Vibativ?)
  • Ceftaroline Fosamil (Teflaro? / Zinforo)
  • Fidaxomicin (Dificid / Dificlir?)
  • Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
  • Dalbavancin (Dalvance? / Xydalba?)
  • Tedizolid Phosphate (Sivextro?)
  • Oritavancin (Orbactiv? / Nuvocid?)
  • Ceftolozane-Tazobactam (Zerbaxa?)
  • Ceftazidime-Avibactam (Avycaz? / Zavicefta)
  • PHASE III DRUGS

Split by applications, this report focuses on sales, market share and growth rate of Antibacterial Drug Resistance in each application, can be divided into

  • Gram-Positive
  • Gram-Negative

If you have any special requirements, please let us know and we will offer you the report as you want.

Click here to Get free PDF Sample :https://www.grandresearchstore.com/report-sample/united-states-antibacterial-drug-resistance-market-report-2017D

Table of Contents

United States Antibacterial Drug Resistance Market Report 2017
1 Antibacterial Drug Resistance Overview
1.1 Product Overview and Scope of Antibacterial Drug Resistance
1.2 Classification of Antibacterial Drug Resistance
1.2.1 Telavancin (Vibativ?)
1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
1.2.3 Fidaxomicin (Dificid / Dificlir?)
1.2.4 Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
1.2.5 Dalbavancin (Dalvance? / Xydalba?)
1.2.6 Tedizolid Phosphate (Sivextro?)
1.2.7 Oritavancin (Orbactiv? / Nuvocid?)
1.2.8 Ceftolozane-Tazobactam (Zerbaxa?)
1.2.9 Ceftazidime-Avibactam (Avycaz? / Zavicefta)
1.2.10 PHASE III DRUGS
1.3 Application of Antibacterial Drug Resistance
1.3.1 Gram-Positive
1.3.2 Gram-Negative
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antibacterial Drug Resistance (2012–2022)
1.4.1 United States Antibacterial Drug Resistance Sales and Growth Rate (2012–2022)
1.4.2 United States Antibacterial Drug Resistance Revenue and Growth Rate (2012–2022)

2 United States Antibacterial Drug Resistance Competition by Manufacturers
2.1 United States Antibacterial Drug Resistance Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antibacterial Drug Resistance Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antibacterial Drug Resistance Average Price by Manufactures (2015 and 2016)
2.4 Antibacterial Drug Resistance Market Competitive Situation and Trends
2.4.1 Antibacterial Drug Resistance Market Concentration Rate
2.4.2 Antibacterial Drug Resistance Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Antibacterial Drug Resistance Sales (Volume) and Revenue (Value) by States (2012–2017)
3.1 United States Antibacterial Drug Resistance Sales and Market Share by States (2012–2017)
3.2 United States Antibacterial Drug Resistance Revenue and Market Share by States (2012–2017)
3.3 United States Antibacterial Drug Resistance Price by States (2012–2017)

4 United States Antibacterial Drug Resistance Sales (Volume) and Revenue (Value) by Type (2012–2017)
4.1 United States Antibacterial Drug Resistance Sales and Market Share by Type (2012–2017)
4.2 United States Antibacterial Drug Resistance Revenue and Market Share by Type (2012–2017)
4.3 United States Antibacterial Drug Resistance Price by Type (2012–2017)
4.4 United States Antibacterial Drug Resistance Sales Growth Rate by Type (2012–2017)

Browse Complete Report@https://www.grandresearchstore.com/life-sciences/united-states-antibacterial-drug-resistance-market-report-2017D

Contact us:

  • 276 5th Avenue, New York ,
    NY 10001, United States
  • Phone Number :- +1–212–634–4884 / +1–646–781–7170
  • Fax: +1(212)-634–4885
  • help@grandresearchstore.com
Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: